Platelet-Rich Plasma Versus Saline for the Treatment of Vulvar Lichen Sclerosus: Protocol for a Randomized Controlled Trial (Preprint)
Preprint
- 16 November 2024
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Vulvar lichen sclerosus (LS) is a chronic relapsing dermatosis commonly affecting the anogenital region in postmenopausal women, though it can affect people of any age and sex. The current gold standard treatment is lifelong topical steroid application to reduce symptoms and prevent the progression of disease, causing irreversible architectural change to the vulval tissue. LS is associated with decreased quality of life and increased risk of vulvar neoplasia. Alternatives to current treatments are highly desired by both clinicians and patients. Platelet-rich plasma (PRP) is an autologous blood product containing high concentrations of platelets and growth factors and is hypothesized to promote wound healing. PRP has been reported to improve symptoms of LS in several case reports and uncontrolled trials. OBJECTIVE This study aims to evaluate the efficacy of PRP versus saline injections to improve the clinical signs and symptoms of LS. METHODS This is a protocol for a 12-month, single-center, parallel-group, double-blind, randomized controlled trial evaluating the efficacy of PRP for LS compared to saline. Adult female patients with biopsy-proven LS who are otherwise in good health but are nonresponders to topical steroid treatment prior to inclusion are eligible for the trial. A total of 68 participants will be randomly allocated via a random number generator to receive either PRP or saline injections to areas of the vulva with LS. All participants will be blinded to the intervention received. Participants will be followed up with assessments of clinical LS signs, subjective symptom scores, and quality of life questionnaires by blinded assessors at 4 timepoints: baseline, 6 weeks, 6 months, and 12 months. The primary outcome is the clinical scoring system for LS—the total LS score. RESULTS Recruitment commenced in May 2020 and concluded in November 2023. This study closed in September 2024 due to slow recruitment. Data are being analyzed in 2025, and results are expected to be published in late 2025. CONCLUSIONS This study will evaluate the safety and efficacy of PRP injections compared to those of saline injections for the treatment of vulvar LS, potentially providing a novel therapeutic option for patients who do not respond to topical steroids. CLINICALTRIAL Australia and New Zealand Clinical Trials Registry ACTRN12618001321235p; Universal Trial Number: U1111-1207-4893; anzctr.org.au/Trial/Registration/TrialReview.aspx?id=375536 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/68871Keywords
All Related Versions
- Published version: JMIR Research Protocols, 14 (1), e68871.
This publication has 31 references indexed in Scilit:
- Platelet rich plasma for the management of urogynecological disorders: the current evidenceCurrent Opinion in Obstetrics and Gynecology, 2022
- Risk of Vulvar Squamous Cell Carcinoma in Lichen Sclerosus and Lichen Planus: A Systematic ReviewJournal of Obstetrics and Gynaecology Canada, 2022
- Use of Platelet-rich Plasma for Vulvovaginal Autoimmune Conditions Like Lichen SclerosusPlastic and Reconstructive Surgery - Global Open, 2016
- Long-term Management of Adult Vulvar Lichen SclerosusJAMA Dermatology, 2015
- Will Your Doctor Do What You Want?2013
- An Autoimmune Phenotype in Vulvar Lichen Sclerosus and Lichen Planus: A Th1 Response and High Levels of MicroRNA-155Journal of Investigative Dermatology, 2012
- 334 SO YOU THINK YOU CAN DECIDE WHICH TREATMENT IS BEST FOR YOU? YOU CAN'T. NOR CAN YOUR DOCTOR! BUT HELP IS UNDERWAYRadiotherapy and Oncology, 2012
- A validated self-administered female pelvic floor questionnaireInternational Urogynecology Journal, 2009
- Platelet-Rich Plasma: A Review of Biology and Applications in Plastic SurgeryPlastic and Reconstructive Surgery, 2006
- Platelet-rich plasmaOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1998